ASO Author Reflections: An Objective Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy.
作者信息
Conroy Patricia C, Alseidi Adnan, Adam Mohamed A
机构信息
Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
Department of Surgery, Division of Surgical Oncology, University of California, San Francisco, San Francisco, CA, USA.
出版信息
Ann Surg Oncol. 2022 Mar;29(3):1575-1576. doi: 10.1245/s10434-021-11022-w. Epub 2021 Nov 12.
Abstract
摘要
相似文献
1
ASO Author Reflections: An Objective Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy.ASO作者反思：微创胰十二指肠切除术的客观医院手术量阈值
Ann Surg Oncol. 2022 Mar;29(3):1575-1576. doi: 10.1245/s10434-021-11022-w. Epub 2021 Nov 12.
2
ASO Author Reflections: Minimally Invasive Pancreaticoduodenectomy for Pancreatic Cancer: Are We Maximizing Delivery of Multimodality Therapy?ASO作者反思：胰腺癌的微创胰十二指肠切除术：我们是否在最大限度地提供多模式治疗？
Ann Surg Oncol. 2022 Nov;29(12):7804-7805. doi: 10.1245/s10434-022-12427-x. Epub 2022 Aug 13.
3
Pancreaticoduodenectomy in elderly patients: a special place for minimally invasive surgery?
Hepatobiliary Pancreat Dis Int. 2016 Dec;15(6):665-666. doi: 10.1016/s1499-3872(16)60149-2.
4
ASO Author Reflections: Robot is the Missing Link for Vascular Resection During Minimally Invasive Pancreatoduodenectomy.ASO作者反思：机器人是微创胰十二指肠切除术中血管切除的关键环节。
Ann Surg Oncol. 2024 Mar;31(3):1939-1940. doi: 10.1245/s10434-023-14456-6. Epub 2023 Oct 19.
5
Minimally Invasive Techniques for Pancreatic Resection.胰腺切除术的微创技术。
Surg Oncol Clin N Am. 2021 Oct;30(4):747-758. doi: 10.1016/j.soc.2021.06.007. Epub 2021 Jul 22.
6
Minimally invasive pancreatic resection in the light of evidence state of the art.微创胰腺切除术的证据现状。
Rozhl Chir. 2021 Summer;100(5):213-217. doi: 10.33699/PIS.2021.100.5.213-217.
7
Re-defining a high volume center for pancreaticoduodenectomy.重新定义胰十二指肠切除术的高容量中心。
HPB (Oxford). 2021 May;23(5):733-738. doi: 10.1016/j.hpb.2020.09.009. Epub 2020 Sep 28.
8
"Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer. Practice Patterns and Short-term Outcomes Among 7061 Patients".“微创与开放胰十二指肠切除术治疗癌症。7061例患者的实践模式和短期结果”
Ann Surg. 2017 Aug;266(2):e26. doi: 10.1097/SLA.0000000000001315.
9
ASO Author Reflections: Is Minimally Invasive Ivor-Lewis the Future of Esophagectomy?ASO作者反思：微创艾弗-刘易斯手术会是食管癌切除术的未来吗？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):719-720. doi: 10.1245/s10434-019-07772-3. Epub 2020 Jun 21.
10
Response to the Letter to the Editor: Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer Is Associated With Increased 30-day Mortality.
Ann Surg. 2017 Aug;266(2):e26-e27. doi: 10.1097/SLA.0000000000001316.
本文引用的文献
1
Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.确定微创胰十二指肠切除术安全性的医院容量阈值：当代切点分析。
Ann Surg Oncol. 2022 Mar;29(3):1566-1574. doi: 10.1245/s10434-021-10984-1. Epub 2021 Nov 1.
2
The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection.《迈阿密微创胰腺切除术循证指南》。
Ann Surg. 2020 Jan;271(1):1-14. doi: 10.1097/SLA.0000000000003590.
3
Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers.比较低、高容量中心微创与开腹胰十二指肠切除术的短期和肿瘤学结局。
Ann Surg. 2019 Dec;270(6):1147-1155. doi: 10.1097/SLA.0000000000002810.
4
Defining a Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy in the United States.确定美国微创胰十二指肠切除术的医院手术量阈值
JAMA Surg. 2017 Apr 1;152(4):336-342. doi: 10.1001/jamasurg.2016.4753.
Zotero 插件